BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3134807)

  • 1. Cranial MR imaging in neurofibromatosis.
    Bognanno JR; Edwards MK; Lee TA; Dunn DW; Roos KL; Klatte EC
    AJR Am J Roentgenol; 1988 Aug; 151(2):381-8. PubMed ID: 3134807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cranial MR imaging in patients with von Recklinghausen's disease (neurofibromatosis type I).
    Hashimoto T; Tayama M; Miyazaki M; Kuroda Y; Hiura K; Hujino K; Yamashita K
    Neuropediatrics; 1990 Nov; 21(4):193-8. PubMed ID: 2127081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis types 1 and 2: cranial MR findings.
    Aoki S; Barkovich AJ; Nishimura K; Kjos BO; Machida T; Cogen P; Edwards M; Norman D
    Radiology; 1989 Aug; 172(2):527-34. PubMed ID: 2501822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR imaging of cerebellopontine angle and internal auditory canal lesions at 1.5 T.
    Press GA; Hesselink JR
    AJR Am J Roentgenol; 1988 Jun; 150(6):1371-81. PubMed ID: 3259382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Encephalic lesions in neurofibromatosis: clinical manifestations and typical magnetic resonance findings].
    Magnaldi S; White RM; Bryan RN
    Radiol Med; 1990 Dec; 80(6):796-807. PubMed ID: 2126389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of magnetic resonance tomography on diagnosis and therapy in patients with intracranial manifestation of neurofibromatosis (Recklinghausen disease).
    Kiwit JC; Nicola N; Roosen N; Wechsler W; Gahlen D; Bock WJ
    Neurosurg Rev; 1987; 10(4):283-6. PubMed ID: 3146711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gadolinium DTPA in magnetic resonance. Clinical experience in intracranial pathology].
    Bradac GB; Riva A; Berger T; Stura G; Duca S
    Radiol Med; 1988; 76(1-2):33-7. PubMed ID: 3399707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracranial visual pathway gliomas in children with neurofibromatosis.
    Packer RJ; Bilaniuk LT; Cohen BH; Braffman BH; Obringer AC; Zimmerman RA; Siegel KR; Sutton LN; Savino PJ; Zackai EH
    Neurofibromatosis; 1988; 1(4):212-22. PubMed ID: 3152473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Craniocervical manifestations of neurofibromatosis: MR versus CT studies.
    Mayer JS; Kulkarni MV; Yeakley JW
    J Comput Assist Tomogr; 1987; 11(5):839-44. PubMed ID: 3116048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain tumors in children with von Recklinghausen neurofibromatosis.
    Hochstrasser H; Boltshauser E; Valavanis A
    Neurofibromatosis; 1988; 1(4):233-9. PubMed ID: 3152475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiological investigation of sellar region masses in children.
    Miller JH; Peņa AM; Segall HD
    Radiology; 1980 Jan; 134(1):81-7. PubMed ID: 6765992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Magnetic resonance imaging diagnosis of occupied lesions in cerebellopontine angle area:a report of 78 cases].
    Huang L; Xu WG; Fu YF; Gao W
    Ai Zheng; 2005 May; 24(5):591-5. PubMed ID: 15890104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis.
    Mirowitz SA; Sartor K; Gado M
    AJR Am J Roentgenol; 1990 Feb; 154(2):369-73. PubMed ID: 2105032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Optic glioma in 3 patients with Recklinghausen disease].
    Moro F; Cavallaro N
    Klin Monbl Augenheilkd; 1995 Mar; 206(3):178-83. PubMed ID: 7616728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Von Recklinghausen's neurofibromatosis with multiple intracranial tumors.
    Deutsch EC
    Ear Nose Throat J; 1984 Mar; 63(3):141-8. PubMed ID: 6425035
    [No Abstract]   [Full Text] [Related]  

  • 16. [The MR tomographic findings in cranial manifestations of neurofibromatosis].
    Vestring T; Fahrendorf G; Bongartz G; Reuther G; Peters PE
    Rofo; 1990 Dec; 153(6):678-82. PubMed ID: 2176321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascularity of meningiomas and neuromas: assessment with dynamic susceptibility-contrast MR imaging.
    Maeda M; Itoh S; Kimura H; Iwasaki T; Hayashi N; Yamamoto K; Ishii Y; Kubota T
    AJR Am J Roentgenol; 1994 Jul; 163(1):181-6. PubMed ID: 8010210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gadolinium DTPA in a MR study of expansive lesions of the cranial base].
    Bartolozzi C; Olmastroni M; Dal Pozzo G; Petacchi D
    Radiol Med; 1988 Sep; 76(3):152-7. PubMed ID: 3175068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging of optic nerve lesions: value of gadopentetate dimeglumine and fat-suppression technique.
    Hendrix LE; Kneeland JB; Haughton VM; Daniels DL; Szumowski J; Williams AL; Mark LP; Czervionke LF
    AJR Am J Roentgenol; 1990 Oct; 155(4):849-54. PubMed ID: 2119121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.
    Kuenzle C; Weissert M; Roulet E; Bode H; Schefer S; Huisman T; Landau K; Boltshauser E
    Neuropediatrics; 1994 Dec; 25(6):295-300. PubMed ID: 7770126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.